Outcomes of patients awaiting lung transplantation after the implementation of donation after brain death at a single Chinese center.
10.1007/s11684-021-0899-5
- Author:
Yuling YANG
1
;
Xinnan XU
1
;
Ming LIU
1
;
Yanfeng ZHAO
1
;
Yongmei YU
1
;
Xiaogang LIU
1
;
Chang CHEN
1
;
Gening JIANG
1
;
Wenxin HE
2
Author Information
1. Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.
2. Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200092, China. 0wenxinhe@tongji.edu.cn.
- Publication Type:Journal Article
- Keywords:
donation after brain death;
lung transplantation;
waitlist
- MeSH:
Humans;
Brain Death;
Retrospective Studies;
China;
Lung Transplantation;
Pulmonary Disease, Chronic Obstructive/surgery*
- From:
Frontiers of Medicine
2022;16(5):760-765
- CountryChina
- Language:English
-
Abstract:
Voluntary contribution has become the only source of donor lungs in China since 2015. To elaborate the outcomes of patients awaiting lung transplantation (LTx) after the implementation of donation after brain death, we performed a retrospective study that encompassed 205 patients with end-stage lung disease who registered for LTx at Shanghai Pulmonary Hospital from January 1, 2015 to January 1, 2021. A total of 180 patients were enrolled in the study. The median waiting time was 1.25 months. Interstitial lung disease (ILD) (103/180, 57.2%) and chronic obstructive pulmonary disease (COPD) (56/180, 31.1%) were the most common diseases in our study population. The mean pulmonary artery pressure (mPAP) of patients in the died-waiting group was higher than that of the survivors (53.29±21.71 mmHg vs. 42.11±18.58 mmHg, P=0.002). The mortality of patients with ILD (34/103, 33.00%) was nearly twice that of patients with COPD (10/56, 17.86%) while awaiting LTx (P=0.041). In the died-waiting group, patients with ILD had a shorter median waiting time than patients with COPD after being listed (0.865 months vs. 4.720 months, P=0.030). ILD as primary disease and mPAP > 35 mmHg were two significant independent risk factors for waitlist mortality, with hazard ratios (HR) of 3.483 (95% CI 1.311-9.111; P=0.011) and 3.500 (95% CI 1.435-8.536; P=0.006). Hence, LTx is more urgently needed in patients with ILD and pulmonary hypertension.
